Providing Free Nicotine Patches to Quitline Smokers
Launched by UNIVERSITY OF CALIFORNIA, SAN DIEGO · Nov 21, 2012
Trial Information
Current as of August 28, 2025
Completed
Keywords
ClinConnect Summary
Tobacco smoking leads to nicotine dependence and serious health consequences. Telephone counseling has been shown to improve smokers' chances of quitting and is the most accessible of the three evidence-based forms of counseling (individual face-to-face, group, and telephone). It is well established that offering free NRT can attract many more smokers to call a quitline. However, how much the offer of free NRT helps quitline callers quit successfully is less well documented. There is currently no consistent guideline for quitline practice. We want to determine whether two weeks' worth of st...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years or older
- • Current smoker
- • First time quitline caller
- • Not eligible for nicotine patches through other programs such as MediCal or Los Angeles County which provides free nicotine patches
- • English and/or Spanish speaking
- • Valid phone number
- • Valid address
- • CA resident
- • Gave consent to participate in study and evaluation
- Exclusion Criteria:
- • Contraindication(s) to nicotine patches
- • Uses a form of tobacco other than cigarettes
- • Plans to use Chantix
About University Of California, San Diego
The University of California, San Diego (UCSD) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust focus on translational medicine, UCSD leverages its interdisciplinary approach to explore groundbreaking therapies and interventions across a wide range of medical fields. The university's state-of-the-art facilities and collaboration with top-tier faculty and researchers ensure a comprehensive and ethical framework for conducting clinical trials, ultimately aiming to enhance patient outcomes and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Diego, California, United States
Patients applied
Trial Officials
Shu-Hong Zhu, Ph.D.
Principal Investigator
University of California, San Diego
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials